Mary Steinbach
Impact in
-
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
Papers in
- Hematology 16
- Multiple Myeloma Research and Treatments 14
- Oncology 12
- CAR-T cell therapy research 6
- Peptidase Inhibition and Analysis 5
- Lung Cancer Research Studies 2
- Neutropenia and Cancer Infections 2
- Co-authors
- Djordje Atanackovic (8 shared papers)Tim Luetkens (8 shared papers)Sabarinath Venniyil Radhakrishnan (4 shared papers)Sara Yousef (4 shared papers)Neelam Bhardwaj (3 shared papers)Douglas W. Sborov (8 shared papers)Jens Panse (3 shared papers)Tibor Kovacsovics (4 shared papers)
- Journals
- Blood (5 papers)Human Vaccines & Immunotherapeutics (2 papers)Seminars in Oncology Nursing (2 papers)Neurology Neuroimmunology & Neuroinflammation (1 paper)Hematology/Oncology Clinics of North America (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Mary Steinbach
21 papers receiving 165 citations
Peers
Comparison fields: 5 of 41
- Hematology 48
- Oncology 85
- Physiology 11
- Immunology 37
- Genetics 8
Countries citing papers authored by Mary Steinbach
This map shows the geographic impact of Mary Steinbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Steinbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Steinbach more than expected).
Fields of papers citing papers by Mary Steinbach
This network shows the impact of papers produced by Mary Steinbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Steinbach. The network helps show where Mary Steinbach may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Steinbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 32 | |
| 2 | 2015 | 31 | |
| 3 | 2023 | 20 | |
| 4 | 2017 | 15 | |
| 5 | 2020 | 13 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 6 | |
| 8 | 2016 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 5 | |
| 11 | 2017 | 4 | |
| 12 | 2024 | 4 | |
| 13 | 2017 | 3 | |
| 14 | 2023 | 3 | |
| 15 | 2017 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 2021 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2015 | 1 |
About Mary Steinbach
Mary Steinbach is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 168 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), CAR-T cell therapy research (6 papers), Peptidase Inhibition and Analysis (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Research Studies (2 papers), Immunotherapy and Immune Responses (2 papers), Protein Degradation and Inhibitors (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (48 citations), Oncology (85 citations), Physiology (11 citations), Immunology (37 citations) and Genetics (8 citations). Mary Steinbach has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Djordje Atanackovic, Tim Luetkens, Sabarinath Venniyil Radhakrishnan, Sara Yousef, Neelam Bhardwaj, Douglas W. Sborov, Jens Panse, Tibor Kovacsovics, Christina Wilson and James Marvin. Their work appears in journals such as Blood, Human Vaccines & Immunotherapeutics, Seminars in Oncology Nursing, Neurology Neuroimmunology & Neuroinflammation and Hematology/Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.